Navigate:

StoreFront / Immunohistochemistry / Antibodies / All Antibodies / CD142 (BSB-143), MMab

<		Previous Product
		Next Product		>

cd142, anti-cd142, tf, anti-tf, coagulation factor iii, coagulation factor 3, anti-tf, anti-coagulation factor, tissue f MAIN

CD142 (BSB-143), MMab

Presentation:

Price: $202.00

SKU:	BSB-3718-3
Antibody type:	Mouse Monoclonal
Clone:	BSB-143
Isotype:	IgG2b
Concentrate Dilution:	1:50-1:200
Localization:	Cytoplasmic, Membranous
Tissue Control:	Placenta, Cervix, Colon, Pancreas, Brain
Species Reactivity:	Human, Mouse, Rat

DescriptionDocumentationAsk a QuestionPrice Details

Intended Use

For In Vitro Diagnostic Use

Summary and Explanation

CD142, also known as Tissue Factor (TF) or Coagulation Factor III or Thromboplastin, is encoded by the F3 gene located on chromosome 1p21.3. CD142 /TF is a 46 kDa sized integral membrane glycoprotein. Upon complex formation with coagulation factor VII, extrinsic blood coagulation is activated by a catalytic cascade that involves specific proteolysis.

CD142 antibody is not only associated with the progression, but also with the overall survival rate of many cancers, including breast, gastrointestinal, liver, pancreatic, and prostate cancer. A study that investigated CD142 antibody expression in non-small-cell lung cancer (NSCLC) found that immunohistochemical staining was increased in NSCLC patients with metastasis, compared to patients without metastasis, indicating the critical role of CD142 in the progression of NSCLC. A study found increased CD142 levels in breast cancer tissue as well as a correlation between poor survival and high levels of CD142 expression in breast cancer patients. Overexpression of TF in fibrosarcoma, in gastric cancer cells and in melanoma cells enhances tumour growth by diminishing the transcription of antiangiogenic thrombospondins and/or by increasing the transcription of pro-angiogenic VEGF.

The SARS-CoV-2 virus triggers the synthesis and release of pro-inflammatory cytokines, including IL-6 and TNF-α and also promotes downregulation of ACE-2, which promotes a concomitant increase in levels of angiotensin II (AT-II). Both TNF-α and AT-II have been implicated in promoting overexpression of tissue factor (TF) in platelets and macrophages. Additionally, the generation of antiphospholipid antibodies associated with COVID-19 may also promote an increase in TF. TF may be a critical mediator associated with the development of thrombotic phenomena in COVID-19.

Presentation

CD142 antibody is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.

Synonyms: cd142, anti-cd142, tf, anti-tf, coagulation factor iii, coagulation factor 3, anti-tf, anti-coagulation factor, tissue factor, anti-tissue factor

Specification Sheets

IVD

Safety Data Sheets

SDS

There are currently no questions about this product.
Ask a Question

Option	SKU	Price
Presentation: 3 ml Predilute	BSB-3718-3	$202.00
Presentation: 7 ml Predilute	BSB-3718-7	$363.00
Presentation: 15 ml Predilute	BSB-3718-15	$639.00
Presentation: .1 ml Concentrate	BSB-3718-01	$211.00
Presentation: .5 ml Concentrate	BSB-3718-05	$458.00
Presentation: 1 ml Concentrate	BSB-3718-1	$727.00
Presentation: Control Slides [5]	BSB-3718-CS	$77.05

(805) 692-2768

sales@biosb.com

Returning Customer?

Shopping Cart

The Shopping Cart is currently empty

Enter Coupon

Secure Checkout

CD142 (BSB-143), MMab

Intended Use

Summary and Explanation

Presentation

Subscribe to our mailing list